ArticleScientific reports2017

Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.

Dillon M Voss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.